ABSTRACT
INTRODUCTION
Thalassemia is the most common anemia with hereditary base. 1, 2 Iran is one of the most common countries for thalassemia major 3 and there are at least 20000 patients affected by thalassemia major. 4 This severe hereditary anemia necessitates lifelong blood transfusion and according to this modality of treatment metabolic, endocrine and growth abnormality occur. 5, 6 Chronic blood transfusion in thalasssemia major or other hemolytic disorders such as sickle cell anemia could decrease chronic hemolysis and change the micronutrient status. 7, 8 Copper is a trace element with high level in heart, kidney, brain, and also had an important role in the development of connective tissue, nerve and bone. 9 Other enzymatic reactions are reduction of superoxide dismutase, cytochrome oxidase, lysil oxidase, dopamine hydroxylase and other oxidases with reduction in molecular oxygen function. [10] [11] [12] Multiple nutrient products contain copper and high levels of copper find in meats, oysters, nuts, seeds, dark chocolate and whole grain. 13 In some reports, copper deficiency in major thalassemia patients has been described as a cause of retarded growth and delayed sexual maturity. [14] [15] [16] In the evaluation of copper status in patients with thalassemia major, some reports revealed paradoxical results with copper excess and deficiency. 15, 17 The aim of this study is to evaluate copper status in a large group of patients with thalassemia patients and determine how many and what types of patients need copper supplement. 
MATERIALS AND METHODS
This prospective cross-sectional study was carried out on thalassemia patients in Ali-Asghar Hospital, Zahedan, Iran. The study was approved by the Ethics Committee, Medical University. Inclusion criteria included the following: (a) age over 5 years, (b) documented reports on diagnosis of thalassemia major, transfusion-dependent patients and (c) normal renal and liver function. Patients were not eligible for inclusion if they had liver, renal or gastrointestinal disease, special diet including vegetarian diet, or consumed multi-vitamin plus factitious mineral water. Blood samples were taken from eligible patients after an overnight fast of 12-14 hours. Blood samples were then centrifuged within 45 minutes of collection. Serum samples were stored at -80°C until analysis (at Razavi Hospital affiliated with Mashhad Medical University) by flame atomic absorption spectrometry Varian, Australia (AA240fs). According to this instrument, the normal level of copper is reported in the range of 70 to 150 µgr/dl. In this study, serum level lower than 70µgr/dl was defined as deficiency and higher than 150 µgr/ dl was defined as copper excess. All data were entered into an SPSS file and reported according to mean and standard deviation. The chi-square test, ANOVA and t-test were used for statistical analysis of data. Upon approval of the University Research Ethics Committee, the informed consent was obtained before the study.
RESULTS
Of 370 patients with thalassemia major over 5 years of age enrolled in this study, 333 were eligible and evaluated. The study included both males (n=192, 57.7%) and females (n=141, 42.3%). Of whom, 90 (27%) were aged 5-10 yrs, 80 (24%) were aged 10-15 yrs and 49% were above 15 years of age. 
DISCUSSION
The prospective cross-sectional study on 333 patients with thalassemia major showed that copper deficiency is more prevalent (32.1%) in south-east Iran. This conclusion is inconsistent with the previous findings in Iran and other parts of the world. In comparison with previous studies, more thalassemia patients within different age ranges were recruited into this study. Mansi et al., studied 42 patients (20 males and 22 females) with thalassemia major in the age range of 4-14 years old. 18 Contrary to our conclusion in regard to number of patients, copper level and gender predominance, there was no significant difference between sex and serum copper level.
In a study conducted by Mahyar on 40 cases, the mean copper status was 152.42 ±24.17. 19 No copper deficiency was recognized and copper status was reported as normal in the study group. The copper range and mean copper status was 100-200.5 and 152.42±24.17μg/dl, respectively. No statistically significant difference was observed between copper status and demographic characteristics in patients with thalassemia major. There was also no significant difference between copper status and serum ferritin level or age, BMI, iron chelation therapy and blood transfusion. In a study performed by Claster on patients with thalassemia major, copper level was above the upper limit of normal, 9 reflecting complete contrast to our findings. Another study conducted by Nasr et al., showed severe copper deficiency in patients with thalassemia major, while no normal copper level or copper excess was observed. 20 There was statistically significant difference between copper deficiency and mean serum mean copper status 60.60±15.71µgr/dl (p<0.001).
CAI Min-nin revealed that the copper status in patients with thalassemia major was higher than the normal range. 21 Canellas et al., found that copper concentration in sickle cell anemia patients was 20% higher than control group. 22 In a study conducted by Ellen, no copper abnormality or deficiency was observed in patients with thalassemia major. 
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CONCLUSION
Copper status has been reported normal or high in the vast majority of studies. Previous studies were conducted with small sample sizes, while our study included a large number of thalassemic patients with copper deficiency, normal and elevated copper level. The results of this study show that what types of patients with thalassemia major can receive alternative treatment. Regarding the small amount of micronutrient supplement in daily regimen, future studies will likely attempt to develop a regimen including adequate amounts of micronutrient supplement for patients.
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